摘要
目的观察在治疗小儿腹泻时使用双歧杆菌四联活菌片和蒙脱石散药物的治疗效果。方法随机选取98例2019年2月至2020年3月在本院治疗的小儿腹泻患者作为试验对象,使用等量随机电脑法将其等分为两组,即对照组和观察组,每组49例。对照组使用双歧杆菌四联活菌片进行治疗,观察组在对照组基础上联合蒙脱石散药物进行治疗,对比两组患者的疾病治疗效果和不良反应(抽搐、呼吸道感染、呕吐、便秘)出现的情况。结果观察组治疗有效率为97.959%,对照组为85.714%,观察组治疗效果高于对照组,此外观察组不良反应出现概率为4.082%,对照组为16.327%,对照组高于观察组,组间数据差距大,存在统计意义(P<0.05)。结论在治疗小儿腹泻时,要使用双歧杆菌四联活菌片联合蒙脱石散进行治疗,这样能够提高治疗效果,建议医院采取推广。
Objective To observe the therapeutic effect of bifidobacterium quadruple live bacteria tablets and montmorillonite powder in the treatment of diarrhea in children.Methods 98 children with diarrhea treated in our hospital from February 2019 to March 2020 were randomly selected as test subjects,and they were divided into two groups,namely,control group and observation group,49 cases in each group.The control group was treated with bifidobacterium quadrupled live bacterium tablets,and the group was treated on the basis of the control group combined with montmorillolithic drug.Results The effective rate was 97959%in the observation group and 85.714%in the control group.The therapeutic effect in the observation group was higher than that in the control group.In addition,the probability of adverse reactions in the observation group was 4.02%and that in the control group was 16.327%.The data difference between the two groups was statistically significant(P<0.05).Conclusion In the treatment of infantile diarrhea,the bifidobacteria and the tetralogy of tetralogy of the montmorillonites can be used for the treatment,so that the treatment effect can be improved,and the hospital is recommended to take promotion.
作者
林志延
LIN Zhi-yan(Huidong County people’s Hospital,Huizhou,Guangdong 516300)
出处
《智慧健康》
2020年第16期86-87,90,共3页
Smart Healthcare
关键词
双歧杆菌四联活菌片
蒙脱石散
临床疗效
Bifidobacterium quadruple living bacteria tablets
Montmorillonite powder
Clinical efficacy
